EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations

Mar Bennasar iD, Antoni Borrell iD

Prenatal Diagnosis · 2026-08-05

DOI: 10.1002/pd.70231 ↗

At a glance

Übersichtsarbeit in Prenatal Diagnosis, published online on 2026-08-05. Written by Mar Bennasar and 1 co-authors. Institution: BCNatal. Barcelona Center for Maternal-Fetal and Neonatal Medicine, Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Hospital Clínic de Ba…. 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy. Clinically significant non‐RhD alloantibodies, particularly those of the Rh (c, C, E), Kell, Kidd, Duffy, and MNS systems, are associated with variable risk of fetal anemia and account for an increasing proportion of alloimmunized pregnancies requiring specialized prenatal care. Most diagnostic algorithms and management protocols are based on evidence derived from RhD alloimmunization. Although these frameworks are often extrapolated to other alloantibodies, important differences exist regarding antibody titration and critical thresholds, the diagnostic accuracy of non‐invasive fetal antigen genotyping, and the risk and timing of fetal and neonatal interventions. These differences underscore the need for antibody‐specific considerations in the prenatal diagnosis and management of non‐RhD alloimmunization. Though advances in non‐invasive diagnostic techniques have improved risk stratification and optimized prenatal management, individualized care pathways in alloimmunized pregnancies are needed. This review will focus on the current strategies for prenatal diagnosis and risk assessment in pregnancies complicated by non‐RhD red cell alloimmunization.

Authors and institutions

  • BCNatal. Barcelona Center for Maternal-Fetal and Neonatal Medicine, Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
  • Department of Medical-surgical Specialties, Medical Sciences School, Universitat de Barcelona, Barcelona, Catalonia, Spain.

ORCID profiles: Mar Bennasar, Antoni Borrell

Cite

APA

Bennasar, M., & Borrell, A. (2026). The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations. Prenatal Diagnosis. https://doi.org/10.1002/pd.70231

Vancouver

Bennasar M, Borrell A. The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations. Prenatal Diagnosis. 2026. doi:10.1002/pd.70231

BibTeX
@article{Bennasar2026,
  author = {Bennasar, Mar and Borrell, Antoni},
  title = {The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70231}
}
Start for free →